We observed a slight reduction in C2VTrp1 tumor growth in mice receiving TRP1 adoptive cell therapy compared to mice receiving no T cells, consistent with prior reports showing limited tumor control by TRP1 T cells in the absence of other therapies (14, 48, 57). This evidence concerns the gene PRSS1 and neoplasm.